The patient experience is shaped in every interaction, not just with clinical care. Kaziah Riston, housekeeper with Cincinnati Children’s EVS team, proves that as she makes her daily rounds. Earlier this year, she was given a glowing note from a family that saw her kindness as an action of going above and beyond, which led…
If CMS and private payers are serious about whole-person health, reimbursement structures must align with the workforce actually delivering that care. Payment pathways should recognize the value of the broader care team and enable the seamless integration of their expertise with the objective data generated through connected devices and programs like RPM. The post Behavior…
Coral Care’s Series A round was led by Haymaker Ventures, with participation from FCA Ventures, Peterson Ventures, Alleycorp, Reach Capital, Jefferson River Capital, Greymatter Capital, Mother Ventures and Charge Ventures. The post Coral Care Raises $13M to Scale In-Home Pediatric Therapy appeared first on MedCity News.
Rhythm Pharmaceuticals drug Imcivree met the body mass index reduction goals of a Phase 3 test in hypothalamic obesity, an acquired form of obesity stemming from dysregulation of the MC4R pathway in the hypothalamus. The engineered peptide drug is already approved for two genetically driven types of obesity. The post Rhythm Pharma Drug Lowers BMI…
Sarepta Therapeutics attributed the Phase 3 failure to the Covid-19 pandemic, during which many patients missed multiple doses of its Duchenne muscular dystrophy therapies. The company plans to discuss with the FDA traditional regulatory approvals based on the totality of data that includes real world evidence from the years these drugs have been commercially available…
Roche is buying 89bio to get pegozafermin, a drug currently in two Phase 3 studies for the fatty liver disease MASH. Beyond the $2.4 billion payable when the deal closes, another $1.1 billion in contingent value right payments is tied to the achievement of commercial milestones for the projected blockbuster seller. The post Roche’s Metabolic…
Check out news from Oral Genome, BeMe Health, Noetik, and Vouched. The post StartUPDATES: New Developments from Healthcare Startups appeared first on MedCity News.
The Host Julie Rovner KFF Health News @jrovner @julierovner.bsky.social Read Julie’s stories. Julie Rovner is chief Washington correspondent and host of KFF Health News’ weekly health policy news podcast, “What the Health?” A noted expert on health policy issues, Julie is the author of the critically praised reference book “Health Care Politics and Policy A…
Apella raised an $80 million Series B funding round to expand its AI-powered platform designed to help hospitals optimize their operating rooms. The startup’s tool promises to boost surgical volume, reduce clinician burnout and improve patient access without adding new staff or facilities. The post Apella Lands $80M Series B to Optimize Hospital ORs appeared…
VBC models deliver significant benefits for CKD management by coordinating medical, behavioral, and social support through multidisciplinary teams. This approach enables providers to personalize care, address barriers to access, and use data-driven strategies to identify and prioritize high-risk patients. The post Closing the CKD Care Gap with Value-Based Care Models appeared first on MedCity News.